Skip to main content
. 2024 Oct 23;10(4):e004727. doi: 10.1136/rmdopen-2024-004727

Figure 3. Pretreatment, post-R-CNOP and post-CAR-T PET-CT and CT scans. CAR-T: chimeric antigen receptor T cell; DS: Deauville Score; DLBCL: diffuse large B cell lymphoma; PD: progressive disease; PET: positron emission tomography; PR: partial response; R-CNOP: rituximab, cyclophosphamide, mitoxantrone, vincristine and prednisolone; SD: stable disease.

Figure 3